Recherche
Résultats 1-10 de 20
-
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet (London, England), 2017Article dans une revue scientifique -
Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial
Journal of clinical oncology, 2016, 34, 2028-+Article dans une revue scientifique -
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
American journal of hematology, 2016, 91, 179-184Article dans une revue scientifique -
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Lancet (London, England), 2016, 387, 2402-2411Article dans une revue scientifique -
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
The Lancet. Oncology, 2015, 16, 704-715Article dans une revue scientifique -
Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Haematologica, 05-2018, 108 (5)Article dans une revue scientifiquetexte intégral -
F-fdg-pet dissemination features in diffuse large b cell lymphoma are prognostic of outcome
Journal of nuclear medicine . official publication, Society of Nuclear Medicine, 14-06-2019Article dans une revue scientifique -
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Leukemia, 26-09-2019, 33, 2762–2766Article dans une revue scientifiquetexte intégral -
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial
Blood Cancer Journal, Nature Publishing Group, 20-08-2021, 11, 147Article dans une revue scientifiquetexte intégral -
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Neuro-oncology, 2016, 18, 1297-1303Article dans une revue scientifique